Proximal Roux-en-Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P-glycoprotein Substrates

Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers

(2014) Margreke J. E. Brill et al.   CLINICAL PHARMACOKINETICS

Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

(2013) M Ulvestad et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Obesity-Associated Nonalcoholic Fatty Liver Disease

(2013) Yusuf Yilmaz et al.   Clinics in Liver Disease

Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity

(2013) Alini Schultz et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Influence of Bypass Procedures and Other Anatomical Changes in the Gastrointestinal Tract on the Oral Bioavailability of Drugs

(2013) Julie De Smet et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes

(2013) Jan Peter Yska et al.   OBESITY SURGERY

Metabolic/Bariatric Surgery Worldwide 2011

(2013) Henry Buchwald et al.   OBESITY SURGERY

The Effectiveness and Risks of Bariatric Surgery

(2013) Su-Hsin Chang et al.   JAMA Surgery

Pharmacokinetic and Pharmacodynamic Alterations in the Roux-en-Y Gastric Bypass Recipients

(2012) Sweta Tandra et al.   ANNALS OF SURGERY

Predicting Drug Candidate Victims of Drug-Drug Interactions, using Microdosing

(2012) Marie Croft et al.   CLINICAL PHARMACOKINETICS

Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects

(2012) Lena M.S. Carlsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gastric Bypass Surgery Is Followed by Lowered Blood Pressure and Increased Diuresis - Long Term Results from the Swedish Obese Subjects (SOS) Study

(2012) Peter Hallersund et al.   PLoS One

Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin

(2012) Gunn Signe Jakobsen et al.   SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES

Pharmacokinetic considerations in Roux-en-Y gastric bypass patients

(2011) A. Smith et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Interplay of Metabolism and Transport in Determining Oral Drug Absorption and Gut Wall Metabolism: A Simulation Assessment Using the “Advanced Dissolution, Absorption, Metabolism (ADAM)” Model

(2011) A. S. Darwich et al.   CURRENT DRUG METABOLISM

Trends in Use of Bariatric Surgery, 2003−2008

(2011) Ninh T. Nguyen et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Membrane transporters in drug development

(2010)   NATURE REVIEWS DRUG DISCOVERY

Significantly Altered Systemic Exposure to Atorvastatin Acid Following Gastric Bypass Surgery in Morbidly Obese Patients

(2009) I B Skottheim et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A systematic review of drug absorption following bariatric surgery and its theoretical implications

(2009) R. Padwal et al.   Obesity Reviews